NCT05080140Unknown不适用
Investigate the Effect of Ezetimibe, Simvastatin, and Omega 3- Fatty Acids on Dyslipidemia Patients: a Pharmacokinetics Based Study
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 入组人数
- 3
- 试验地点
- 1
- 主要终点
- Reduction of Total cholesterol
研究概览
简要总结
This randomized controlled pharmacokinetic based study will be carried out on patients with both sexes and various ages, plasma triglycerides levels, clinical health disorders and using different agents for treatment of their hyperlipidemia in order to access the optimal drug therapy with best cost effectiveness in the elderly cases under investigation.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients of dyslipidemia with high triglyceride level (200 to 499 mg/100 ml).
- •Total cholesterol level more than 200 mg/100 ml
- •Male and female
- •Age 35 - 70 years
排除标准
- •- Hypersensitivity of drugs
- •Liver toxicity
- •-Patients suffering from renal dysfunction
研究组 & 干预措施
Simvastain + ezetimibe + omega
干预措施: Ezetimibe 10mg (Drug)
Ezetimibe
干预措施: Ezetimibe 10mg (Drug)
Simvastatin+ Ezetimibe
干预措施: Ezetimibe 10mg (Drug)
结局指标
主要结局
Reduction of Total cholesterol
时间窗: 3 months
reduction of LDL
次要结局
未报告次要终点
研究者
Yasmine Farouk
Teacher Assistant - clinical pharmacy department
Misr University for Science and Technology
研究点 (1)
Loading locations...
相似试验
终止
4 期
Ezetimibe Plus Simvastatin Versus Simvastatin in Patients With Hypercholesterolemia and Coronary Risk Factors (P03405)AtherosclerosisHypercholesterolemiaNCT00651014Organon and Co82
终止
3 期
Effect of Ezetimibe Plus Simvastatin on Flow-Mediated Brachial Artery Vasoactivity in Subjects With Primary Hypercholesterolemia (Study P03336)AtherosclerosisHypercholesterolemiaNCT00651391Organon and Co28
已完成
3 期
A Research Study to Evaluate MK0653 (Ezetimibe) and Simvastatin, Given Together and Alone, on Intestinal Absorption of Cholesterol (0653-050)(COMPLETED)CholesterolNCT00652301Organon and Co40
已完成
3 期
A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/20 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 20 mg Tablets in Participants With High Cholesterol (MK-0653C-185 AM1)HypercholesterolemiaNCT01370590Organon and Co406
已完成
3 期
A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/40 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 40 mg Tablets in Participants With High Cholesterol (MK-0653C-190 AM1)HypercholesterolemiaNCT01370603Organon and Co328